TOP STORIES

• REGULATORY No Prior Talks with US Drug Makers for Deferred PMP Price Cuts: Health Minister
  March 3, 2025

• REGULATORY J&J’s Lazcluze, Genmab’s Tivdak and More Drugs in Line for Japan Approval
  February 28, 2025

• ORGANIZATION JPMA President Demands Rethink of Social Security Expenditure Cap
  February 27, 2025

• ORGANIZATION Japan Pharma Lobbies Likely to Enter Yasukawa/Miyabashira Era toward FY2026 Reform
  February 26, 2025

• ACADEMIA 1st CP Inhibitor Approved for Sarcoma, Could This Be a Breakthrough to Treatment of More Subtypes?
  February 25, 2025

• REGULATORY Japan Approves CSL’s HAE Med Andembry, Tecentriq Sarcoma Use, and More
  February 21, 2025

• REGULATORY Pfizer Pulls Japan NDA for Hemophilia Gene Therapy Beqvez as Program Called Off Globally
  February 20, 2025

• BUSINESS LTL Pharma Sees 30% Drop in Gaster Sales after New LLP Coverage Rollout
  February 19, 2025

• REGULATORY Espha’s Januvia Generic on Approval Roster towards June Listing
  February 18, 2025

• REGULATORY Japan to Approve EquMet Generics, More Copycats toward June Listing
  February 17, 2025

• REGULATORY J&J’s Lazcluze, Genmab’s Tivdak, and More Up for MHLW Panel Review on Feb. 27
  February 14, 2025

• BUSINESS Regeneron to Upsize Japan Workforce after Libtayo Transfer
  February 13, 2025

• BUSINESS Cheplapharm Set to Expand LLP Deals to 20 APIs, Sees Opportunities Despite Headwinds
  February 12, 2025

• ORGANIZATION US Lobbies Send Letters of Protest to Japan Embassy over Off-Year Revision, CEA
  February 10, 2025

• BUSINESS Bain Picks Up Mitsubishi Tanabe for Over 500 Billion Yen
  February 10, 2025

• BUSINESS AstraZeneca Looks to Keep No.1 Spot in Japan Oncology Space, Driven by Bispecific Antibodies
  February 7, 2025

• BUSINESS Celltrion Set for 6 Biosimilar Filings in 2 Years, Sees Japanese Data Waiver as a Boon
  February 6, 2025

• REGULATORY Japan’s 1st Hemophilia B Gene Therapy Up for Panel Review on Feb. 19
  February 6, 2025

• COMMENTARY Companies Welcome Generic Drug Fund, but Fret Pricing and Regulations
  February 5, 2025

• BUSINESS Astellas to Revamp Management in April, Consolidate R&D Functions
  February 5, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• …
• Next ›
• 最終 »